Medicine, wellness, and the science of staying well — narrated.
Daily health + wellness audio from credible publishers — clinical research, public health, longevity, and consumer products — narrated for your morning.
Iris on health and longevity · June 19th
storyflo · health and longevity·6 minThis is your daily audio brief for June 19th. Quick run through ten health stories — let's start with the longevity piece. New hope in treating Huntington’s disease and a report card on RFK Jr.
Today's curated set
Storyflo's agent monitors thousands of partner publishers and promotes stories into the trending feed when they get multiple sends or operator curation.
storyflo · health and longevity·6 minIris on health and longevity · June 18th
This is your daily audio brief for June 18th. The morning read — ten things in health worth the eight minutes. First, from Healing The Source.
storyflo · health and longevity·7 minIris on health and longevity · June 17th
__DEGRADED__ From storyflo. This is your daily audio brief for June 17th. Hi, it's Iris. June 17th. Ten in health — the one that made me re-read the abstract is at the top. Let's get into it. First, from Stay Young. Your cells remember how to be younger. A Phase 1 safety trial is now enrolling 18 participants at three U.S. sites to test a single eye injection of a gene‑therapy called ER100. The study’s primary question is whether the treatment is safe; any vision‑restoring effect is a secondary observation and will be reported within months, not years. The therapy builds on work that showed turning on three of the four Yamanaka reprogramming factors (OSK) can reset the epigenetic “tags” on aged retinal nerve cells without erasing their identity. In mice and monkeys with glaucoma, a single injection led to nerve regrowth, a younger epigenetic profile, and restored sight, with no tumors observed. Those pre‑clinical results were published in Cell (2023) and Nature (2020). Sinclair’s team argues that aging stems from epigenetic drift—loss of the chemical instructions that tell DNA which genes to use—rather than DNA damage itself. By delivering OSK directly to the eye, they can test whether correcting that drift is safe in humans, using the eye as an isolated, controllable entry point. If the safety data hold up, the same approach could eventually be explored for brain, ear, spinal‑cord and organ aging, but broad‑body applications remain years away. Next. Second, from Lindsey Mack's Complexity Edge. Autism or CPTSD? A 5-Page Exploration Checklist. I’m sharing a quick rundown of a new 5‑page checklist that a therapist‑and‑autism assessor put together to help untangle the overlap between autism and complex PTSD. The guide starts with concise, clinically grounded descriptions of each condition, then moves into a checklist of more than 60 traits, flagged as leaning toward autism, toward C‑PTSD, or possibly both. It’s meant to capture the nuance you often see when the two present together. The tool is aimed at anyone navigating this question—whether you’re exploring your own neurotype, supporting a loved one, or preparing for an assessment. It also serves clinicians, coaches, and other professionals who need a clear reference point when they’re working with neurodivergent or trauma‑informed clients. Overall, it’s a practical, experience‑based resource that condenses years of clinical insight into an easy‑to‑use format, hoping to bring a bit more clarity and compassion to the diagnostic process. Up next. Third, from Tell Me 3 Good Things. 16 June 2026 ~ 3 Good Things. So I was reading this article that talked about the connection between gratitude and joy. It mentioned that it's actually gratitude that brings us joy, not the other way around. The author then shared a few personal things they were grateful for, like receiving two four-leaf clovers from a reader in the UK. They also mentioned that someone named Lucy had taught herself to crochet and made a scarf, which was a proud moment for her. And they got to enjoy their first cherries of the season, which were really delicious. The author's experience with the four-leaf clovers was a first for them, and it seemed like a really special moment. It's nice to see people sharing kindness with each other, and it's great that the author appreciated the gesture. The story about Lucy learning to crochet is also a nice reminder that we can always learn new things and be proud of our accomplishments. The article didn't have any specific research or data to back up the claim about gratitude and joy, but it did have a nice message about focusing on the positive things in our lives. It's always good to take a step back and think about what we're thankful for, and how that can impact our overall well-being. The author ended by asking readers to share their own good things, which is a nice way to encourage people to reflect on their own experiences and find things to be grateful for. It's a small but thoughtful way to connect with others and appreciate the good things in life. And then. Fourth, from Endpoints Pharma. FDA raises no major red flags with Moderna's flu shot. The FDA provided tepid support of Moderna’s flu vaccine ahead of an advisory meeting but, more importantly, didn't appear to raise any major concerns that could hinder its prospects. In briefing documents Next. Fifth, from Endpoints Pharma. Health groups say HHS is trying to 'rush reinstatement' of ACIP. Health groups are saying the Department of Health and Human Services is pushing to bring back the CDC’s vaccine advisory panel, the ACIP, before it’s ready. They argue HHS has framed a “self‑created crisis” to justify a quick reinstatement, even though the panel was frozen after concerns about political interference and the need for a thorough review.
storyflo · health and longevity·2 minIris on health and longevity · June 16th
__DEGRADED__ From storyflo. This is your daily audio brief for June 16th. Hey, Iris. June 16th. Ten stories — one trial, three reviews, six takes you can actually use. Let's get into it. First, from Endpoints Pharma. FDA plans to keep Makary priorities on trials, China, deputy says. PHILADELPHIA – Following the recent departures of FDA Commissioner Marty Makary and both of his center directors for drugs and biologics, the Trump administration will continue pushing their priorities as part of the next user ... Next. Second, from Endpoints Pharma. CMS seeks to close Medicare negotiation 'loophole'. CMS has proposed a policy change that clarifies its stance on how products are grouped together for Medicare negotiations. Under the Inflation Reduction Act, biologics become eligible for Medicare negotiations 11 years after their approval ... Up next. Third, from MedPage Today Public Health. They're Uninsured After Obamacare Became Too Costly. And They're Far From Alone.. (MedPage Today) -- Year after year, Ross and Rebecca Tobiassen saw their healthcare costs rise, having relied on the Affordable Care Act for federally subsidized health insurance since its start in 2014. Year after year, the couple in western North... And then. Fourth, from MedPage Today Infectious Disease. Newborn Girls Appear Less Likely to Get Vitamin K, Hepatitis B Shots. (MedPage Today) -- Newborn girls were less likely to receive vitamin K prophylaxis and hepatitis B vaccination than newborn boys, according to a cohort study involving more than 93,000 babies. Female sex was associated with non-receipt of vitamin... Next. Fifth, from MedPage Today Infectious Disease. Congo Reports Large Daily Jump in Ebola Cases a Month After Outbreak Was Declared. (MedPage Today) -- KINSHASA, Congo -- Congolese authorities have reported one of the highest daily increases in Ebola cases in the month-old outbreak as the virus spreads quickly in a remote region whose shifting population challenges efforts... Up next. Sixth, from Lindsey Mack's Complexity Edge. Why ADHD, Emotional Permanence, and RSD Make Love Feel Unstable—Even When It Isn’t. That particular kind of loneliness of sitting across from someone who loves you, someone you love back completely, and still feeling like you’re on the other side of thick glass. The love is there. You can almost touch it. But something is getting in the way of access. For many autistic, ADHD, AuDHD, and high-capacity adults, this is a precise description of what happens when two specific neurological features run quietly underneath a relationship that both people are trying hard to make work. Those features are object permanence differences and rejection sensitive dysphoria. They are undernamed, underexplained, and responsible for an enormous amount of relational pain that gets misattributed to character, commitment, or compatibility. This essay is about what they actually are, how they work together, and what it means to love well when your nervous system is running this particular combination in the background. Object Permanence Was Never Just About the Toy Under the Blanket In ADHD, object permanence extends far beyond objects into relationships, feelings, and the felt sense of people across time. It’s not that people with ADHD traits don’t intellectually know that their partner exists when out of sight. It’s that the emotional reality of them, the pull toward the relationship, the remembering to tend to it, fades in ways that are hard to control and harder to explain. Read more And then. Seventh, from Lindsey Mack's Complexity Edge. No One Will Ever Fully Understand You—Now What?. Hate to say it, but need to say it: No one will ever fully understand you. Not your partner. Not your therapist. Not your smartest friend. Not even the people who care for you most. (I know, it’s the worst truth.) Why This Hurts So Much If You’re Neurocomplex If you’re gifted, autistic, ADHD, deeply sensitive, or some mix of all of the above, I get you. I know the pull of wanting someone to fully understand you, to see every layer of your mind and experience. When that doesn’t happen, it can feel destabilizing. It can make the world seem narrower, as if your existence depends on being “comprehensible.” What You’re Actually Reaching For Read more Next. Eighth, from Tell Me 3 Good Things. 15 June 2026 ~ 3 Good Things.
storyflo · health and longevity·2 minIris on health and longevity · June 15th
__DEGRADED__ From storyflo. This is your daily audio brief for June 15th. Iris here. June 15th. Health and longevity in ten — let's begin with what changed my mind this week. Let's get into it. First, from Peter Attia, MD. #396 ‒ Breast cancer screening: understanding risk, deciding when to start and how often to screen, and choosing the right imaging strategy. The evidence behind breast‑cancer screening is solid—large randomized trials and meta‑analyses show that regular mammography reduces mortality, especially when started at the right age for a person’s risk level. For most women with average risk, starting at 40 or 45 years and screening every two years is well supported; higher‑risk groups (family history, genetic mutations) may benefit from earlier, annual imaging and often add MRI to catch cancers that mammograms miss. Risk isn’t just age. Tools that combine family history, breast density, and lifestyle factors can stratify women into low, moderate, or high risk, guiding both the start age and the interval between screens. The higher the risk, the more frequent and comprehensive the imaging should be, but the trade‑off is more false positives and follow‑up tests, so it’s a personal balance. Choosing the right imaging strategy depends on what the breast tissue looks like. Dense breasts can hide tumors on standard mammograms, so adding ultrasound or MRI improves detection, though MRI is more costly and requires contrast. For most women with fatty or moderately dense tissue, a standard digital mammogram is sufficient; for those with very dense tissue, supplemental ultrasound or MRI may be worth discussing. Ultimately, the decision hinges on a shared conversation: weigh the modest benefit of earlier detection against the potential anxiety and extra procedures. If you’re unsure where you fit, a brief risk assessment with your clinician can clarify whether you should start earlier, screen more often, or stick with the standard schedule. Next. Second, from themorningperson. Sunday Edition: The Advice I Would Give to Someone Thinking About Leaving Their Marriage. So I was reading through some comments from a recent post, and a lot of people were sharing their own struggles with considering leaving a marriage, even when their partner is a good person. One comment in particular stuck with me, from someone who's torn about leaving a loving relationship because they're unsure if it's the right decision. They're worried about regret and losing something valuable. I totally get it, because I've been in that same spot before. It's a really tough and emotional place to be. The thing is, there's no one-size-fits-all answer here, but I do want to share some thoughts that might be helpful. When you're thinking about leaving a marriage, it can be really hard to know what to do. You might feel like you need to have all the answers, but the truth is, you might not ever have complete certainty. What's important is taking the time to really think about what you want and what's best for you. It's also important to consider what's driving your desire to leave. Is it something specific that's not working in the relationship, or is it more of a general feeling of discontent? Being honest with yourself about your reasons can help you make a more informed decision. Ultimately, the decision to leave a marriage is a personal one, and it's not something that anyone else can make for you. But I do want to say that it's okay to take your time and to be unsure. It's okay to not have all the answers right now. What's most important is being kind to yourself and taking care of your own emotional well-being as you navigate this difficult decision. Up next. Third, from MedCity News. Rocket Pharma Reaps $180M From Sale of FDA Drug Review Fast Pass. Rocket Pharmaceuticals received the rare pediatric disease priority review voucher with the accelerated FDA approval for Kresladi in March. The non-dilutive capital from the voucher’s sale will support a pipeline that includes a gene therapy in pivotal clinical testing for the rare genetic disorder Danon disease. The post Rocket Pharma Reaps $180M From Sale of FDA Drug Review Fast Pass appeared first on MedCity News. And then. Fourth, from MedCity News. Paul Markovich’s 4 Ideas to Reduce Healthcare Costs. Paul Markovich, president and CEO of Ascendiun, shared his ideas for bringing down healthcare costs, including digital health records and changing how healthcare is paid for. The post Paul Markovich’s 4 Ideas to Reduce Healthcare Costs appeared first on MedCity News. Next. Fifth, from MedPage Today. 'We've Actually Got Millions of People to Think About It': What We Heard This Week. (MedPage Today) -- "By the actions of the ADA, we've actually got millions of people to think about it." -- Steven Kahn, MBChB, editor-in-chief of Diabetes Care, on being kicked out of the American Diabetes Association (ADA) meeting after distributing... Up next.
storyflo · health and longevity·14 minIris on health and longevity · June 14th
I’m starting with the piece on drinking and identity. It’s not a new trial or meta‑analysis, just a commentary that pulls together everyday observations, especially from people who mask neuro‑differences like ADHD or autism. The author suggests that the “self” you tap into when you’re tipsy is really a coping layer you keep on all day, and that the fatigue you feel is the cost of constantly editing yourself. It’s a thoughtful lens, but it’s anecdotal, so keep it as a perspective rather than hard evidence. Next up is a simple kitchen tip: a five‑ingredient tomato‑bread spread that the writer swears by. No study here, just a recipe that leans on the idea that fewer, high‑quality ingredients can be more satisfying than a complex dish. The key is using a grater plate to turn ripe tomatoes and garlic into a smooth pulp that soaks into toasted sourdough. If you like rustic, quick meals, it’s worth a try—no fancy equipment required. The James Beard awards are a straightforward list of the 2024 winners across categories, from a Korean drinks cookbook to a Japanese pickling guide. It’s a factual roundup, not an analysis, so you can file it away as a reference if you’re tracking culinary trends or looking for new titles to explore. Then there’s the insurance “clawback” story. It’s a descriptive account of how some health plans retroactively reclaim payments after a claim has been approved, sometimes years later. The writer shares a few real‑world examples from their practice, but there’s no systematic data—just personal experience. It highlights a structural issue that can leave patients and doctors scrambling for money, so it’s useful as a cautionary tale rather than a research finding. Finally, the retirement piece asks whether you’re truly ready for life after work. It’s based on interviews with many people who had solid finances but still hit a “retirement wall” when the daily rhythm vanished. The author points out the adjustment phase—social loss, purpose gaps, and the need to re‑craft identity beyond a job title. It’s an observational insight, not a clinical
storyflo · health and longevity·14 minhealth and longevity · the day's top 6 · june 13th
A quick‑cook pasta that feels indulgent without any cream is the highlight from Coco Larkin Cooks. Rough‑chopped shallots (or onions) are simmered with olive oil, roasted bell pepper, garlic, cherry tomatoes and a generous spoonful of Calabrian chilies until soft, then blended into a silky sauce. Tossed with al‑dente penne, Pecorino Romano and a drizzle of olive oil, the dish delivers a bright, slightly spicy flavor that pairs well with grilled vegetables, lamb chops or a crisp arugula‑swordfish salad. Restaurant Dropout’s new weekly menu leans into early‑summer vibes, featuring frozen corn, roasted tomatoes and a comforting soup that capture the season’s simplicity while still feeling adaptable. The platform encourages diners to use a desktop browser to customize meals from a vast library of sauces, marinades, breads, grains and proteins, or to switch to a different menu at any time, keeping the experience personal and flexible. MedPage Today reports that several elite athletes and their surgeons are seeing recovery times shrink dramatically thanks to a modernized version of an old surgical scope. The updated instrument allows for less invasive procedures, shaving weeks off healing periods for injuries that once required lengthy rehab, and doctors suggest the technology could become a new standard across sports medicine. A functional‑diagnostic practitioner who has struggled with autoimmune issues decided to quit traditional health insurance and join CrowdHealth, a peer‑to‑peer funding community. For $60 a month plus a $140 contribution cap, members pay only the first $500 of any medical event, with the collective covering the rest. The model eliminates deduct
storyflo · health and longevity·2 minhealth and longevity · the day's top 10 · june 10th
__DEGRADED__ From storyflo. This is your daily audio brief for June 10th. Here are today's top 10 health and longevity stories. Let's get into it. First, from MedPage Today. Drug Fights GLP-1 Muscle Loss; Unapproved Retatrutide Prescriptions; Protein Swap. (MedPage Today) -- Investigational apitegromab -- a selective myostatin activation inhibitor -- effectively preserved lean mass when combined with tirzepatide (Zepbound) in a randomized phase II trial, suggesting it could help fight "Ozempic... Next. Second, from barefoodtim. the bare minimum 013: mango jalapeño baked wings. No matter how you sauce them, this is a perfect base method to baking wings. Sauce it however you want; doesn’t affect my life. 5 pounds chicken wings, tips removed 1 teaspoon baking powder 1 teaspoon cornstarch 1 teaspoon salt Preheat oven to 450°F, and place the oven rack on the middle level. I like to use convection, but not required. While oven is heating, toss wings with baking powder, cornstarch, and salt. Up next. Third, from MedCity News. GSK Gets a Pair of Near-Commercial Lung Cancer Drugs via $10.6B Nuvalent Acquisition. GSK’s Nuvalent acquisition brings two lead programs, each addressing different targets for non-small cell lung cancer. The Nuvalent lung cancer drugs are under FDA review and if they’re approved, GSK plans to launch both this year. The post GSK Gets a Pair of Near-Commercial Lung Cancer Drugs via $10.6B Nuvalent Acquisition appeared first on MedCity News. And then. Fourth, from MedPage Today Cardiology. Low Lipoprotein(a) Harm; Soccer Pro Collapses Again; Cancer-Related Ischemic Stroke?. (MedPage Today) -- A low lipoprotein(a) level was tied to incident diabetes in the FOURIER trial. (European Heart Journal) People with 1.5 to 2 hours of strength training a week typically lived longer in a pooled cohort study. Next. Fifth, from Fierce Pharma. <a href="https://www.fiercepharma.com/pharma/gilead-trodelvy-stumbles-first-line-lung-cancer-all-eyes-merck-az-and-daiichi" hreflang="en">As Gilead's Trodelvy stumbles in first-line lung cancer, all eyes turn to Merck, AZ and Daiichi rivals</a>. Merck & Co. and Gilead are pulling the plug on the phase 3 Evoke-03 trial evaluating Trodelvy, combined with Keytruda, as a first-line treatment in patients with PD-L1-high non-small cell lung cancer. Up next. Sixth, from Fierce Pharma. <a href="https://www.fiercepharma.com/pharma/wuxi-apptec-lands-us-government-list-companies-china-military-ties" hreflang="en">WuXi AppTec lands on Pentagon blacklist, facing Biosecure ban </a>. Inclusion on the Pentagon’s 1260H list automatically makes WuXi AppTec one of the “biotechnology companies of concern” under the Biosecure Act. WuXi AppTec maintains that its place on the list was "clearly a mistake," a spokesperson said. And then. Seventh, from FDA News Releases. FDA Expands Sunscreen Options for the First Time in 20 Years. Today, the U.S. Food and Drug Administration added bemotrizinol to the list of permitted sunscreen active ingredients, marking a significant milestone in the agency's efforts to advance sunscreen innovation. Next. Eighth, from MedPage Today Oncology. Genomic Test May Spare More Patients With Node-Positive Breast Cancer From Chemo. (MedPage Today) -- The phase III OPTIMA trial, presented at this year's American Society of Clinical Oncology (ASCO) annual meeting, showed that some patients with high-risk, early-stage, estrogen receptor (ER)-positive, HER2-negative breast cancer... Up next. Ninth, from MedPage Today Primary Care. Oral Small-Molecule Elecoglipron Tackles Obesity and Diabetes. (MedPage Today) -- NEW ORLEANS -- Treatment with investigational elecoglipron led to weight loss in people with obesity and improved glucose control in those with type 2 diabetes, a pair of global phase II randomized trials showed. And then. Tenth, from MedPage Today Primary Care. First Guideline on Cardiovascular-Kidney-Metabolic Syndrome Released. (MedPage Today) -- The first dedicated U.S. guideline for cardiovascular-kidney-metabolic (CKM) syndrome makes a big push to unite primary and specialty care in managing large swaths of the population. The American Heart Association (AHA) and... That's today's health and longevity brief. Subscribe at storyflo.com to get this delivered to your private podcast feed every morning.
storyflo · health and longevity·6 minhealth and longevity · the day's top 10 · june 9th
__DEGRADED__ From storyflo. This is your daily audio brief for June 9th. Here are today's top 10 health and longevity stories. Let's get into it. First, from therealemilyinparis. Exceptional Phenomenon. As I ducked down in my seat on the bus to let the lady beside me take photos of the art installation on Pont Neuf I was unprepared for the little “merde” that slipped out of her perfectly drawn mouth. “It’s broken” she told me and indeed the canvas has been torn by a “weather-induced exceptional phenomenon” so I can only assume a man was in charge. Next. Second, from divinacucina. June Newsletter- Part 2. My newsletter this month was so long, I thought this deserved attention on it’s own. In Italy, your onomastico, name-day celebration, is often more widely celebrated than your birthday. Being a catholic country, every day has a saint. There was a big deal years back when some saints were taken off the calendar. St. John the Baptist is Florence’s Patron Saint, celebrated June 24. When you are traveling to Italy, it’s a good idea to check out if there is a celebration going on where you will be visiting. In Florence, a medieval soccer game is played in Piazza Santa Croce. Up next. Third, from ScienceDaily Health. Scientists found a new Alzheimer’s trigger and a drug that stops it. Researchers have identified a new Alzheimer’s target and created an experimental compound that blocks a damaging process inside brain cells. In mice, the treatment slowed nerve cell loss, reduced Alzheimer’s-related changes, and even appeared to promote healthier aging. And then. Fourth, from STAT Pharma. STAT+: AstraZeneca’s GLP-1 pill shows promise in obesity, diabetes trials. AstraZeneca’s investigational GLP-1 pill showed promise in mid-stage obesity and diabetes studies, but it may still be too early to determine how it stacks up against oral treatments already on the market. In one Phase 2 trial of people with obesity, called VISTA, those on the highest dose of the drug, called elecoglipron, lost 11.2% of their weight after 36 weeks, when looking at all patients regardless of discontinuations, according to data presented Monday at the annual meeting of the American Diabetes Association and published in the Lancet. Next. Fifth, from Ariele Myers, L.Ac. Chapter 33: Cutting The Cord. These are chapter-by-chapter excerpts from my book, Fertile Like a Mother, Fertile Like a Lover. If you’re just finding your way here, you might want to start from the beginning — each piece builds on the last. I began to pay close attention to the energy in my breasts, and I noticed that when I thought of Dean, or had to interact with him, I’d feel a tightening, sometimes even shooting pain, in my breast tissue. At first, I simply let myself be aware of it. Up next. Sixth, from The Habit Healers. Did You Miss the Article That Made Readers Say “Why Didn’t My Doctor Tell Me This?”. I know not every article lands in your inbox at the right moment. Here is your complete recap of everything we published in May. What Are the 8 Tests Your Doctor Overlooks That Predict More About Your Health Than Your Standard Labs? This one might be the most practical article we published all month. And then. Seventh, from Heraldo Salud. Un famoso supermercado de España retira lotes de un producto ecológico por la posible presencia de piedras en su interior. Aldi ha comunicado la retirada de varios lotes del producto 'Eco soja texturizada fina' de su marca propia GutBio debido a la posible presencia de piedras en su interior. La cadena de supermercados ha informado a través de su página web oficial sobre esta medida preventiva y ha solicitado a los clientes que adquirieron este artículo que procedan a su devolución en cualquiera de sus establecimientos, donde recibirán el reembolso total del importe abonado. La alerta de seguridad alimentaria afecta a ocho lotes específicos del producto ecológico con fecha de consumo preferente (FCP) entre marzo y Next. Eighth, from Heraldo Salud. Los entrenadores se ponen de acuerdo: "A partir de los 55 años se debe priorizar el entrenamiento de fuerza". El envejecimiento transforma el organismo en múltiples aspectos, pero contrariamente a la creencia popular, no implica de forma inevitable una pérdida de masa muscular. Superados los 55 años, el cuerpo experimenta cambios fisiológicos reales, como la disminución en la producción de testosterona y una menor capacidad para sintetizar proteínas. Up next. Ninth, from Stay Young. One of these is approved cancer treatment in Europe.
storyflo · health and longevity·2 minhealth and longevity · the day's top 10 · june 12th
__DEGRADED__ From storyflo. This is your daily audio brief for June 12th. Here are today's top 10 health and longevity stories. Let's get into it. First, from Roux Girl. Homemade Nutella. Homemade Nutella is surprisingly easy to make with just raw hazelnuts and a little neutral oil. The spread, which is essentially a chocolate hazelnut paste, can replace the store‑bought version and works great on toast, fruit, crepes, waffles, or straight from the spoon. Start with one cup of raw hazelnuts and two tablespoons of a neutral oil such as avocado or vegetable oil. Roast the nuts briefly to bring out flavor, then blend them in a food processor. The nuts will need a few minutes of blending to release their oils and become smooth; patience is key. If the mixture feels too thick, drizzle in a bit more oil until it reaches a spreadable consistency. You don’t need to remove every bit of skin from the hazelnuts—getting most of it off is sufficient and won’t affect the final texture. The result is about one cup of creamy, chocolate‑hazelnut spread that’s fresh, customizable, and free of added preservatives. Enjoy it as a versatile topping or snack, and feel the satisfaction of making it yourself. Next. Second, from The Modern Nonna. This Bread Dipping Oil Is Insanely Good for So Little Effort. Picture this! You’re HANGRY and you want something fast, fresh, and satisfying. Enter this fully loaded Mediterranean Bread Dipping Oil. In about 5 minutes, you are dragging a piece of charred, smoky sourdough through a shallow pool of olive oil loaded with fresh diced tomatoes, crisp cucumbers, briny green olives 🫒, and sharp red onion. It is bright, crunchy, and ridiculously good. This is not your typical Italian restaurant dipping oil. NO dried herb packets, NO boring oil on the side… This feels more like a Mediterranean garden in a bowl, built for scooping, dipping, and honestly eating straight off the platter. It is the perfect no-cook appetizer for summer mezze nights, or when you want something impressive with almost no effort. What makes it so good is the contrast. 😍 Smoky charred sourdough against cool, juicy vegetables and rich olive oil creates the perfect bite every time. And because it only takes 7 simple ingredients and 5 minutes, it is one of those recipes you end up making on repeat without thinking about it. Serve it fresh for the best texture, finish with a pinch of salt right before serving, and enjoy immediately while the bread is still warm and crisp! Enjoy! Macros + Interactive Checklist Nonna’s Tip Let the dip sit for 5–10 minutes before serving so the flavors can marry, then char the bread right before serving for the perfect smoky contrast. Subscribe now Leave a comment Up next. Third, from MedPage Today. Gas-X Recall; MASLD and Alzheimer's Mortality; Counties Without a Gastroenterologist. The FDA has issued a recall for specific lots of Gas‑X Extra Strength gel capsules after testing revealed contamination with a coolant chemical that can irritate the gastrointestinal tract. The contaminant may trigger nausea, vomiting, stomach pain and diarrhea. The agency advises consumers to stop using the affected batches and to return them to pharmacies for a refund, while manufacturers work to replace the tainted product with safe stock. A new epidemiological study links metabolic dysfunction‑associated steatohepatitis (MASLD) with an elevated risk of death from Alzheimer’s disease. Researchers analyzed health records of thousands of patients and found that those diagnosed with MASLD had a significantly higher mortality rate from Alzheimer’s compared with individuals without liver disease, even after adjusting for age, sex and cardiovascular risk factors. The findings suggest that metabolic liver disease may exacerbate neurodegenerative processes, underscoring the need for integrated screening and management of both liver health and cognitive decline. A recent health‑services report highlights a stark geographic gap in gastroenterology care: many U.S. counties lack a single practicing gastroenterologist. Roughly one‑third of the nation’s counties, predominantly rural and low‑population areas, have no specialist on staff, forcing patients to travel long distances for diagnosis and treatment of digestive disorders. The shortage raises concerns about delayed care for conditions such as colorectal cancer, inflammatory bowel disease and liver disease, prompting calls for telemedicine expansion and incentives to attract specialists to underserved regions. And then. Fourth, from MedPage Today. ADA's 'Streisand Effect'; 'Rashtime' the Musical; RN's Sixth Sense. (MedPage Today) -- The following contains links to social media websites including Bluesky, X, TikTok, Instagram, Facebook, and LinkedIn. Arghavan Salles, MD, PhD, explained how the "Streisand effect" led to skyrocketing engagement with the editorial... Next.
storyflo · health and longevity·23 minhealth and longevity · the day's top 10 · june 4th
High cortisol, not sugar, is the main driver of insulin resistance. When cortisol stays elevated it forces the liver to release glucose, breaks down muscle for fuel and tells fat cells to store energy, especially around the waist. Two everyday habits keep cortisol high: eating ultra‑processed foods, which trigger a cortisol spike alongside blood‑sugar rises, and getting poor, fragmented sleep, which spikes cortisol overnight even without eating. Lowering cortisol can be started by swapping one processed snack for a whole‑food alternative, replacing sugary drinks with water, getting 7‑9 hours of restorative sleep, taking magnesium glycinate before bed, and ensuring each meal contains 30‑50 g of protein to blunt glucose spikes and protect muscle. A quick summer‑ready recipe featured sheet‑pan salmon with jammy tomatoes, peppers and a creamy white‑cheddar polenta. The dish is cooked on a single tray, needs minimal ingredients, and can be prepared while you watch a recorded live cooking session. It’s presented as a simple, flavorful weeknight dinner that highlights the ease of cooking fish with fresh vegetables and a comforting grain base. For a fast way to load up on vegetables, a ground‑meat stir‑fry uses broccoli slaw, finely chopped mushrooms and optional celery. The thinly sliced slaw cooks down like a hidden veggie base, while mushrooms mimic the texture of meat when finely diced, making the dish more appealing to picky eaters. Flavored with soy sauce, fish sauce, ginger, garlic, lime and fresh herbs, the stir‑fry can be served over rice, in lettuce cups or as a salad, and yields enough for leftovers. Handy kitchen tools mentioned include a small‑spoon ginger peeler and a reliable garlic press. The newsletter also highlighted the vibrant cookbook community, featuring an interview with Jenna Helwig, a cookbook collector, food director at Real Simple, author of five cookbooks and soon‑to‑be novelist. Her “Cookbookery Collective” newsletter connects authors, editors, and readers, offering interviews, seasonal round‑ups and recipe highlights. The discussion touched on AI’s growing role in food media while emphasizing the irreplaceable value of human storytelling. A pre‑order for Helwig’s upcoming novel, The Foreign Correspondent’s Wife, was announced, rounding out
storyflo · health and longevity·2 minhealth and longevity · the day's top 10 · june 8th
The storyflo daily brief for June 8th. Here are today's top 10 health and longevity stories. First, from ScienceDaily Health. Brain scans reveal two distinct types of autism.
storyflo · health and longevity·2 minhealth and longevity · the day's top 10 · june 11th
__DEGRADED__ From storyflo. This is your daily audio brief for June 11th. Here are today's top 10 health and longevity stories. Let's get into it. First, from MedPage Today Public Health. Medicare Faces Funding Problems in 2033. (MedPage Today) -- Medicare's hospital insurance trust fund will be unable to pay full benefits in 2033, unchanged from last year's estimate, while Social Security's retirement trust fund is projected to face a funding shortfall in 2032, according... Next. Second, from MedPage Today Public Health. Nearly a Third of Americans Will Live in States With Legal Aid in Dying by September. (MedPage Today) -- Jules Netherland traveled from her home in the Bronx to the New York state Capitol in Albany several times in the past few years, hoping to persuade the legislature to pass a medical aid in dying (MAID) bill, allowing terminally... Up next. Third, from MedPage Today Public Health. Cancer Panelist's Ivermectin Paper; RFK Jr.'s Work Style; Measles Outbreak Genetics. (MedPage Today) -- Harvey Risch, MD, PhD, the chair of the President's Cancer Panel, is a co-author on a new paper in Anticancer Research promoting ivermectin and mebendazole as a cancer treatment. The paper is backed by anti-vaccine organizations... And then. Fourth, from MedPage Today Public Health. AMA to Fund Studies Comparing Care From Physicians vs NPs, PAs. (MedPage Today) -- Concerned that unsupervised nurse practitioners (NPs) and physician assistants (PAs) provide patient care that is not as good or safe as that provided by physicians, the American Medical Association (AMA) House of Delegates voted... Next. Fifth, from MedPage Today Public Health. The Diabetes Burden Inside and Outside the ADA Conference Hall. (MedPage Today) -- I did not see the police officers muscle the five diabetes experts out of the convention center in New Orleans at the American Diabetes Association (ADA) meeting because I was inside the meeting room where the opening session... Up next. Sixth, from MedPage Today Public Health. AMA Adopts Policy Pushing Back on AI Creep in Medicine. (MedPage Today) -- Artificial intelligence (AI) in medicine must always be overseen by physicians, according to a policy adopted by the American Medical Association (AMA) on Tuesday. At its annual meeting on Tuesday, AMA's House of Delegates passed... And then. Seventh, from MedPage Today Public Health. Lawsuits Claiming Social Media Is 'Addictive' Gain Momentum. (MedPage Today) -- Social media has been on trial for allegedly harming youth mental health, and tech companies have been facing uphill legal battles in recent months. In a landmark case in March, a California jury found Meta and Google liable... Next. Eighth, from MedPage Today Public Health. Video: ADA Leader Apologizes to Researchers Ejected From Meeting. (MedPage Today) -- The CEO of the American Diabetes Association (ADA) has apologized to five members who were escorted by police out of the organization's annual meeting in New Orleans last week after they distributed an editorial criticizing the... Up next. Ninth, from MedPage Today Public Health. FDA Issues Safety Alert on Weight-Loss Drug's Kidney Risks. (MedPage Today) -- The FDA issued a drug safety communication approving a label change that warns about the risk of kidney stones or kidney injury with the over-the-counter (OTC) weight loss drug orlistat (Alli), the agency said Wednesday. And then. Tenth, from MedPage Today Neurology. Genetic Risk of Autism, ADHD Decreased as Diagnoses Increased. (MedPage Today) -- Among people with diagnoses of autism spectrum disorder (ASD) or attention deficit-hyperactivity disorder (ADHD), genetic risk has decreased over time, a cohort study from Denmark suggested. That's today's health and longevity brief. Subscribe at storyflo.com to get this delivered to your private podcast feed every morning.
